The cell-based assay market was valued at USD 14.7 Billion in 2017 and is expected to reach at USD 31.93 Billion by 2025 growing at a Compound Annual Growth Rate (CAGR) of 9% from 2018 to 2025. In the dynamic landscape of biomedical research and drug discovery, the demand for accurate, efficient, and cost-effective methods is ever-increasing. Cell-based assays, a cornerstone of modern research, have emerged as indispensable tools in drug development, toxicity testing, and understanding disease mechanisms. As the pharmaceutical and biotechnology industries intensify their quest for precision medicine, the global cell-based assay market is witnessing unprecedented growth.
Browse the full report at @https://www.sheeranalyticsandi....nsights.com/market-r
